Mobile electrocardiography (mECG) devices can go places a standard 12-lead electrocardiography system can't, with fewer technicians in tow, but it doesn't have the same functionality — their most ...
An asymptomatic male patient with definite LQTS with a normal ECG and QTc who was flagged by the AI. Photo Credit: J. Martijn Bos and Michael Ackerman. A new artificial intelligence (AI) solution ...
Please provide your email address to receive an email when new articles are posted on . AliveCor announced it received FDA 510(k) clearance for its mobile, handheld ECG device for the calculation of a ...
NEW YORK--(BUSINESS WIRE)--AccurKardia, a software company that provides clinical-grade, device agnostic, automated ECG (“electrocardiogram”) analytics, today announced the first study showcasing the ...
AliveCor is also offering a service called InstantQT™ to assist in measuring QT intervals through an FDA-cleared, ECG processing software. The Food and Drug Administration (FDA) has cleared the ...
Please provide your email address to receive an email when new articles are posted on . BOSTON — Artificial intelligence using deep neural networks identified patients with congenital long QT syndrome ...
Researchers assessed AliveCor’s KardiaMobile 6L EKG device by comparing it to a 12-lead EKG, which is typically used to evaluate QTc. Mayo Clinic cardiology researchers used more than 1.6 million ...
This cohort study assessed ECG parameters in transgender men and women before and after use of gender-affirming hormone therapies. Testosterone use in transgender men was associated with shorter ...
There were 252 patients with EKG results included for the analysis; they were given concomitant therapy for median 7 days. This article is written live from ID Week 2017 Annual Meeting in San Diego, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback